KDM4D and cancer: JIB-04 is a pan-selective inhibitor of various proteins in the KDM family, with a high selectivity for KDM4D (55) and has been used both in vitro to inhibit cancer cell activity and in vivo to inhibit different types of cancer growths (55–57) and it increases survival rates in mice (55).